SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as investors digest China-US trade developments and their potential impact on tech. Community discussions revolve around market manipulation, with some bracing for a downturn while others see continued upside driven by AI and earnings. A resilient V-recovery is noted amid concerns about regional banks.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending as discussions revolve around its potential in quantum-safe blockchain and cybersecurity solutions, especially after the company's recent demonstration of quantum-resistant Bitcoin. The community is weighing BTQ's technology against competitors, with some highlighting its vertically integrated approach and real-world applications, while others debate its valuation and future prospects in the rapidly evolving quantum computing sector.

HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.

HCM II Acquisition Corp - Ordinary Shares - Class A

HCM II Acquisition Corp.

HCM II Acquisition Corp, symbol HOND, is trending due to its upcoming merger with Terrestrial Energy, anticipated to be voted on soon. Community discussions highlight the potential for the stock to catch up to the valuation of peers like $OKLO post-merger, with some anticipating a pullback before a longer-term rise. Some are relating the potential of HOND to the trends of other recent nuclear SPACs.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending due to a proposed acquisition of Larvotto Resources, sparking significant community discussion around the potential implications of this deal. Investors are weighing the potential benefits of UAMY becoming a major antimony producer outside of China against concerns about potential government stake and stock dilution. The stock is also being discussed in the context of a broader US-Australia strategy around critical minerals.

Bounce Token

Bounce Token is trending as the community discusses its recent price action and potential for significant gains, with some drawing comparisons to past pumps and anticipating a breakout. Conversations revolve around stacked bids, increasing volume, and the possibility of the token reaching previous highs. Some community members highlight the project's fundamentals and real-world use case within the NFT and auction space.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SU Group Holdings is trending as traders on Stocktwits discuss its low float, regained NASDAQ compliance, and a recently announced contract, drawing comparisons to other Hong Kong-based stocks. Community members are speculating about a potential short squeeze due to the high cost to borrow. Some users believe the company's expansion into EV infrastructure and AI-powered solutions could lead to significant gains.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as the community discusses recent data updates from its HARMONi trial, particularly regarding overall survival benefits for ivonescimab in lung cancer patients. While some express concerns about regional differences in trial outcomes and the need for more mature data, others highlight positive trends and potential for FDA approval. Bullish investors point to insider buying and analyst support, while bears cite the company's high valuation and competition in the oncology market.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

Slap is trending due to the recent victory of Karolina Arm, a pro MMA fighter sponsored by Team SLAP. The community is also discussing the project's real-world sports involvement and staking APY, while drawing comparisons to broader crypto market trends with Ethereum and Bitcoin.

Zions Bancorporation NA is a bank holding company, which engages in the provision of full banking and related services. It operates through the following segments: Zions Bank, Amegy Bank, California Bank & Trust, National Bank of Arizona, Nevada State Bank, Vectra Bank Colorado, and The Commerce Bank of Washington. The company was founded on February 17, 1961, and is headquartered in Salt Lake City, UT.

Zions Bancorporation N.A

ZION is trending amid concerns about credit quality and potential loan losses, sparking bearish sentiment and comparisons to past financial crises within the community. Despite analyst upgrades and some arguing the sell-off was overdone, the community is actively discussing insider selling and the broader implications for regional banks. The stock's reaction to past earnings reports and current analyst price targets are also being closely monitored.

Aptera Motors Corp. is an automotive technology company focused on the development, production, and distribution of energy-efficient, solar-powered, battery-electric vehicles. Its flagship product, the Aptera, is a three-wheeled, two-seat solar vehicle designed to reduce reliance on traditional charging by utilizing integrated solar panels. The company was founded by Steve Fambro and Chris Anthony and is headquartered in San Diego, CA.

Aptera Motors Corp - Ordinary Shares - Class B

Aptera Motors Corp

Aptera Motors ($SEV) is trending after its direct listing, marked by significant volatility and trading halts, fueling community debate around potential market manipulation. Some investors are optimistic about the company's solar technology and pre-order numbers, while others express concerns about its design, financial health, and long-term viability, drawing comparisons to other EV companies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Law Offices of Frank R. Cruz Announces Investigation of Complete Solaria Inc. (CSLR) f/k/a Freedom Acquisition I Corporation (FACT) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of Complete Solaria Inc. (CSLR) f/k/a Freedom Acquisition I Corporation (FACT) on Behalf of Investors The Law Offices of Frank R. Cruz...

The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Complete Solaria Inc. (Complete Solaria or Company) (NASDAQ: CSLR) f/k/a Freedom Acquisition I...

Facet Biotech Corporation, a biotechnology company, engages in the identification and development of oncology drugs. Facet was formed through a spin-off of the biotechnology segment of PDL BioPharma, Inc., which was completed on December 18, 2008. It was subsequently acquired by [Abbott Labs](/organization/abbott-labs). The company is headquartered in Redwood City, California.  Its products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company is also developing Elotuzumab, a monoclonal antibody in Phase I/II clinical studies, which binds to a cell surface glycoprotein that is expressed on myeloma cells and normal human cells; PDL192, a monoclonal antibody in Phase I clinical study, which binds to the tumor necrosis factor-like weak inducer of apoptosis receptor; PDL241, a monoclonal antibody in the preclinical stage for immunologic diseases; and TRU-016, a small modular immunopharmaceutical protein therapeutic in Phase I clinical studies for the treatment of B-cell malignancies, such as chronic lymphocytic leukemia and non-Hodgkin's lymphoma, as well as autoimmune and inflammatory disease indications. It has collaboration agreements with Biogen Idec Inc.; Bristol-Myers Squibb Company; and Trubion Pharmaceuticals, Inc. Facet Biotech Corporation also has license agreements with Abbott Laboratories, Inc.; Actinium Pharmaceuticals, Inc.; Genentech, Inc.; Ophthotech Corporation; Progenics Pharmaceuticals, Inc.; and Seattle Genetics, Inc.

Facet Biotech

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

FACT
Freedom Acquisition I Corp - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FACT News

FACTFreedom Acquisition I Corp - Ordinary Shares - Class A